Therapeutic target for the treatment of cancers and related therapies and methods
AssigneeChildren's Medical Center Corporation
InventorsMark Puder, Deepika Nehra, Brian Kalish
Life of this patent
Estimating the term…
Abstract
Disclosed herein are compositions and methods for treating or preventing certain cancers in a subject. In certain embodiments such compositions and methods generally relate to the use of G-coupled protein receptor 40 (GPR40) agonists to inhibit the growth or induce apoptosis of certain cancer cells. The compositions and related methods disclosed herein may be used to treat subjects affected by cancers, such as melanoma, medullary thyroid carcinoma, malignant peripheral nerve sheath tumors and neuroblastoma, and to reduce the incidence of metastases in such affected subjects.
Claims5
A method of treating cancer in a subject affected by cancer, wherein the method comprises administering a composition to the subject and thereby treating the cancer, wherein the composition comprises an effective amount of a G-protein coupled receptor 40 (GPR40) agonist;
- wherein the GPR40 agonist is
- or a pharmaceutically acceptable salt thereof;
- and wherein the cancer is a neuroblastoma.
Dependencies are inferred from the claim text.